EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Adipose derived stromal vascular fraction and fat graft for treating the hands of patients with systemic sclerosis. A randomized clinical trial

Martin Iglesias iD, Iván Torre-Villalvazo, Patricia Butrón-Gandarillas, Tatiana S Rodríguez-Reyna, Erik A Torre-Anaya, Martha Guevara-Cruz iD, Miguel A Flores-Cháirez, Diana B López-Contreras, Joana Y López-Sánchez, Ángel J Ruiz-Betanzos, Ana L Méndez López, Carolina Rubio-Gutierrez und 2 weitere

PLOS ONE · 14.08.2023 · 18 (8) · e0289594

DOI: 10.1371/journal.pone.0289594 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, online erschienen am 14.08.2023. Verfasst von Martin Iglesias und 13 weiteren Autor:innen. Beteiligte Einrichtung: Plastic Surgery Service at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico. Hauptthemen laut MEDLINE: Raynaud Disease, Scleroderma, Systemic. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnologia, Mexico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic Sclerosis in the hand is characteristically evidenced by Raynaud’s phenomenon, fibrosis of the skin, tendons, ligaments, and joints as well as digital ulcers with prolonged healing. Current medical treatment does not always cure these complications. Local adipose-derived stromal vascular fraction administration into the hands has been proposed as an emerging treatment due to its regenerative properties. The objective of this randomized controlled clinical trial was to evaluate the safety and clinical effects of fat micrografts plus adipose derived-stromal vascular fraction administration into the hands of patients with systemic sclerosis.

Methods

This was an open-label, monocentric, randomized controlled study. Twenty patients diagnosed with systemic sclerosis were assigned to the experimental or control group. Fat micrografts plus the adipose derived-stromal vascular fraction were injected into the right hand of experimental group patients. The control group continued to receive only medical treatment. Demographic, serologic data and disease severity were recorded. Digital oximetry, pain, Raynaud phenomenon, digital ulcers number, mobility, thumb opposition, vascular density of the nail bed, skin affection of the hand, serologic antibodies, hand function, and quality of life scores were evaluated in both groups.

Results

The results of the intervention were analyzed with the Wilcoxon rank test, and the differences between the control and experimental groups at 0 days and 168 days were analyzed with the Mann–Whitney U test. Adverse events were not observed in both groups. At the end of the study, statistically significant improvements were observed in pain levels (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Raynaud DiseaseScleroderma, SystemicStromal Vascular FractionQuality of LifeAdipose TissueSkin UlcerHumansTreatment Outcome

Autor:innen und Institutionen

  • Plastic Surgery Service at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
  • Nutrition Physiology Department at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
  • Rheumatology Department at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
  • Fellow-clerk in plastic surgery, Universidad Autonoma de Coahuila, Saltillo, Coahuila, Mexico.
  • Fellow-clerk in plastic surgery, Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
  • Mesenchymal Stem cell Therapy Department at CBCells Biotechnology, Zapopan, Mexico.

ORCID-Profile: Martin Iglesias, Martha Guevara-Cruz

Förderung

  • Consejo Nacional de Ciencia y Tecnologia, Mexico

Zitieren

APA

Iglesias, M., Torre-Villalvazo, I., Butrón-Gandarillas, P., Rodríguez-Reyna, T. S., Torre-Anaya, E. A., Guevara-Cruz, M., Flores-Cháirez, M. A., López-Contreras, D. B., López-Sánchez, J. Y., Ruiz-Betanzos, Á. J., Méndez López, A. L., Rubio-Gutierrez, C., Téllez-Pallares, F., & Nario-Chaidez, F. (2023). Adipose derived stromal vascular fraction and fat graft for treating the hands of patients with systemic sclerosis. A randomized clinical trial. PLOS ONE, 18(8), e0289594. https://doi.org/10.1371/journal.pone.0289594

Vancouver

Iglesias M, Torre-Villalvazo I, Butrón-Gandarillas P, Rodríguez-Reyna TS, Torre-Anaya EA, Guevara-Cruz M, et al. Adipose derived stromal vascular fraction and fat graft for treating the hands of patients with systemic sclerosis. A randomized clinical trial. PLOS ONE. 2023;18(8):e0289594. doi:10.1371/journal.pone.0289594

BibTeX
@article{Iglesias2023,
  author = {Iglesias, Martin and Torre-Villalvazo, Iván and Butrón-Gandarillas, Patricia and Rodríguez-Reyna, Tatiana S and Torre-Anaya, Erik A and Guevara-Cruz, Martha and Flores-Cháirez, Miguel A and López-Contreras, Diana B and López-Sánchez, Joana Y and Ruiz-Betanzos, Ángel J and Méndez López, Ana L and Rubio-Gutierrez, Carolina and Téllez-Pallares, Fernando and Nario-Chaidez, Fabian},
  title = {Adipose derived stromal vascular fraction and fat graft for treating the hands of patients with systemic sclerosis. A randomized clinical trial},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {8},
  pages = {e0289594},
  doi = {10.1371/journal.pone.0289594}
}
Kostenlos starten →